About SCHOTT Pharma
SCHOTT Pharma is a company based in Mainz (Germany) founded in 1884. SCHOTT Pharma offers products and services including syriQ® Syringes, SCHOTT TOPPAC® Syringes, cartriQ® Cartridges, adaptiQ® Vials, and EVERIC® Vials. SCHOTT Pharma operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Mainz, Germany
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Schott Pharma Ag & Co. Kgaa
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SCHOTT Pharma
SCHOTT Pharma offers a comprehensive portfolio of products and services, including syriQ® Syringes, SCHOTT TOPPAC® Syringes, cartriQ® Cartridges, adaptiQ® Vials, and EVERIC® Vials.
Ready-to-use syringes for vaccines and biologics storage
Syringes for sensitive and deep-cold drug applications
Cartridges for peptide and protein injectables
Vials for injectable drug formulations
Vials ensuring drug stability and fill-line efficiency
Ampoules for safe drug storage and administration
People of SCHOTT Pharma
Unlock access to complete
Funding Insights of SCHOTT Pharma
Investors in SCHOTT Pharma
SCHOTT Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Capricorn Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for SCHOTT Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SCHOTT Pharma
Investment portfolio details for SCHOTT Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SCHOTT Pharma
Detailed financials for SCHOTT Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Schott Pharma Comparisons
Peer comparison for SCHOTT Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SCHOTT Pharma
SCHOTT Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
Detailed competitors of SCHOTT Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Schott Pharma
Complete news archive for SCHOTT Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SCHOTT Pharma
SCHOTT Pharma was founded in 1884 and raised its 1st funding round 142 years after it was founded.
SCHOTT Pharma is headquartered in Mainz, Germany. It is registered at Mainz, Rhineland-palatinate, Germany.
SCHOTT Pharma was established in 1884 in Mainz, Germany, within the pharmaceutical sector. Operations focus on drug research and development, alongside fill and finish processes for pharmaceutical products. Regulatory affairs support is also provided to clients. The company maintains its headquarters in Germany, serving global needs in pharmaceutical manufacturing and compliance. Services are tailored to ensure adherence to industry standards and facilitate product readiness for market entry.
SCHOTT Pharma's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
SCHOTT Pharma offers syriQ® Syringes, SCHOTT TOPPAC® Syringes, cartriQ® Cartridges, adaptiQ® Vials, and 2 more products and services.
SCHOTT Pharma has 1 investor. Key investors include Capricorn Partners.